Evidence map›Paper›PMID 31754446›Full record

ArticleJournal of virus eradication2019

Treatment outcomes and factors associated with mortality among individuals with both TB and HIV in the antiretroviral era in Thailand.

Sivaporn Gatechompol, Kamon Kawkitinarong, Gompol Suwanpimolkul, Pairaj Kateruttanakul, Weerawat Manosuthi, Jiratchaya Sophonphan, Sasiwimol Ubolyam, Stephen J Kerr, Anchalee Avihingsanon, Kiat Ruxrungtham

Open access · goldAbstract readEditorial
In one paragraph

Article in Journal of virus eradication, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Factors Associated with Tuberculosis Mortality in Manjung District, Perak, Malaysia.The Malaysian journal of medical sciences : MJMS · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Sivaporn Gatechompol
Kamon Kawkitinarong
Gompol Suwanpimolkul
Pairaj KateruttanakulDepartment of Medicine, Rajavithi Hospital, Bangkok, Thailand.
Weerawat ManosuthiBamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand.
Jiratchaya SophonphanHIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
Sasiwimol Ubolyam
Stephen J KerrHIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
Anchalee Avihingsanon
Kiat RuxrungthamHIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand.
HIV Netherlands Australia Thailand Research Collaboration · THChulalongkorn University · THBamrasnaradura Infectious Diseases Institute · THKing Chulalongkorn Memorial Hospital · THRajavithi Hospital · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to compare treatment outcomes and factors associated with mortality in HIV-1-positive and HIV-1-negative individuals.

methodsWe conducted a cohort study between July 2008 and December 2016. Logistic regression was used to determine factors associated with outcomes and death after tuberculosis (TB) treatment.

resultsA total of 996 individuals with TB, 228 (22.9%) with HIV-1 co-infection and 770 (77.1%) who were HIV-1 negative were reviewed. The overall treatment success rate was 74.3%. The HIV-1-negative individuals with TB had significantly higher treatment success rates (77.2%

conclusionIndividuals who had both TB and HIV-1 in Thailand had lower TB treatment success and higher mortality rates compared with individuals with TB without HIV-1. Strategies to improve ART uptake and to reduce risk of developing active TB among individuals with advanced HIV-1 infection should be scaled up.

Indexed as

antiretroviral therapyrisk factorsTB/HIVtreatment outcome

Identifiers

PMID31754446
PMCPMC6844402
OpenAlexW3021167504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.